TABLE 6.
Group/subgroup | References | Mean difference | 95% CI | P | I 2 |
---|---|---|---|---|---|
Children receiving interventions for <3 mo by zinc dose | |||||
10.1–20 mg/d | (32) | −16.50 | −24.09, −8.91 | NA | |
>20 mg/d | (67) | 0.02 | −0.41, 0.45 | 42 | |
Overall | −0.50 | −1.90, 0.90 | 0.48 | 90 | |
Children receiving interventions for >3 mo by zinc dose | |||||
<5 mg/d | (8, 17, 34) | −4.62 | −15.01, 5.78 | 50 | |
5–10 mg/d | (13, 35, 47, 62, 72) | −1.50 | −5.10, 2.11 | 0 | |
10.1–20 mg/d | (30) | −15.50 | −18.21, −12.79 | NA | |
Zn bolus2 | (28, 33) | −1.03 | −4.08, 2.01 | 0 | |
Overall | −4 | −8.82, 0.82 | 0.10 | 82 | |
Children receiving zinc through zinc gluconate by zinc dose | |||||
5–10 mg/d | (62) | −5.20 | −20.16, 9.76 | NA | |
10.1–20 mg/d | (30) | −15.50 | −18.21, −12.79 | NA | |
Overall | −13.08 | −21.64, −4.53 | 0.003 | 43 | |
Children receiving zinc through zinc sulfate by zinc dose | |||||
<5 mg/d | (34) | −10.25 | −20.18, −0.33 | 0 | |
5–10 mg/d | (8, 13, 35, 47, 72) | −0.63 | −4.26, 2.99 | 0 | |
10.1–20 mg/d | (32) | −16.50 | −24.09, −8.91 | NA | |
Overall | −4.09 | −9.31, 1.12 | 0.12 | 61 | |
Children receiving zinc through zinc acetate by zinc dose | |||||
Zn bolus2 | (28,33) | −1.03 | −4.08, 2.01 | 0 | |
Overall | −1.03 | −4.08, 2.01 | 0.51 | 0 | |
Children receiving zinc vs. placebo by zinc dose | |||||
<5 mg/d | (17) | −7.52 | −21.69, 6.65 | NA | |
5–10 mg/d | (13, 47, 72) | −1.41 | −6.76, 3.93 | 0 | |
10.1–20 mg/d | (30, 32) | −15.61 | −18.17, −13.06 | 0 | |
>20 mg/d | (67) | 0.02 | −0.41, 0.45 | 42 | |
Zn bolus2 | (28, 33) | −0.21 | −3.52, 3.09 | 0 | |
Overall | −4.11 | −6.48, −1.74 | <0.001 | 94 |